Overview

Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
To collect the efficacy and safety information of Zithromax-SR related to their appropriate use in daily practice.
Details
Lead Sponsor:
Pfizer
Treatments:
Azithromycin